skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

About Louisa

UK

+5 year(s) experience

Louisa-Joseph-Pharmaintelligence
Louisa Joseph is an Analyst on the Cardiovascular and Metabolic team. Her disease areas include dyslipidemia, heart failure and ACS. By following market events and trends, she provides high-quality analysis from both clinical and commercial perspectives.

Louisa develops and delivers high-impact research regarding key trends and events in the pharmaceutical and biotechnology industries. She produces pipeline and marketed drug analyses, 10 year-patient/sales based forecasts and in-depth pre/post-conference opinion pieces.

She has a particular interest in analyzing the development of novel therapies from the early pre-clinical and clinical phases through final approval and marketing authorization.

Louisa joined Datamonitor Healthcare in June 2015, after completing a bachelor’s degree in Biochemistry and Pharmacology at the University of Bristol.

Analyst Articles

Articles by Jo

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    Infographic: The Netherlands, A Small Country With Big Ideas

    02 Jul 2019

    Infographic: The Netherlands, A Small Country With Big Ideas

    As the EMA lowers the flags of the 28 EU nations that have flown outside its London offices for 24 years, and prepares to moves its HQ to the Netherlands, Scrip takes a look at Europe’s new pharma regulatory hub.

    Topic business-strategies brexit

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    Interview - Greg Winters Story So Far

    03 Oct 2018

    Interview - Greg Winters Story So Far

    Biochemist Greg Winter has scientifically contributed to some of the pharmaceutical industry's biggest commercial and therapeutic success stories. He tells Scrip how he feels about being labelled a pioneer and why he is still wary of the boardroom.

    Topic cancer

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    Pharma's 2018 Deal-Making Story, So Far

    By Jo Shorthouse 20 Jul 2018

    Pharma's 2018 Deal-Making Story, So Far

    Pharma has been busy making deals this year, while the political winds of change swirl overhead, as our infographic shows. Companies both big and small have been merging to carve out therapeutic niches, return value to shareholders, and position themselves for the next wave of innovation and change.

    Topic business-strategies

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    Welcome to Scrip 100 2017

    24 Apr 2017

    This year the Scrip 100 universe is bigger than ever. We have been tunneling into the 2015 full year financial data of 620 companies to continue the Scrip 100 series, and using this data we can see even more clearly the structure of a top-heavy industry.

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    Where There's A Cure There's Controversy: Raymond Schinazi's Storyarticle 2

    14 Feb 2017

    Where There's A Cure There's Controversy: Raymond Schinazi's Storyarticle 2

    Where There's A Cure There's Controversy: Raymond Schinazi's Story

    Topic Research